153 related articles for article (PubMed ID: 31218102)
1. The miR-873/NDFIP1 axis promotes hepatocellular carcinoma growth and metastasis through the AKT/mTOR-mediated Warburg effect.
Zhang Y; Zhang C; Zhao Q; Wei W; Dong Z; Shao L; Li J; Wu W; Zhang H; Huang H; Liu F; Jin S
Am J Cancer Res; 2019; 9(5):927-944. PubMed ID: 31218102
[TBL] [Abstract][Full Text] [Related]
2. MiR-3662 suppresses hepatocellular carcinoma growth through inhibition of HIF-1α-mediated Warburg effect.
Chen Z; Zuo X; Zhang Y; Han G; Zhang L; Wu J; Wang X
Cell Death Dis; 2018 May; 9(5):549. PubMed ID: 29748591
[TBL] [Abstract][Full Text] [Related]
3. miR-342-3p suppresses hepatocellular carcinoma proliferation through inhibition of IGF-1R-mediated Warburg effect.
Liu W; Kang L; Han J; Wang Y; Shen C; Yan Z; Tai Y; Zhao C
Onco Targets Ther; 2018; 11():1643-1653. PubMed ID: 29615839
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia-dependent expression of MAP17 coordinates the Warburg effect to tumor growth in hepatocellular carcinoma.
Dong F; Li R; Wang J; Zhang Y; Yao J; Jiang SH; Hu X; Feng M; Bao Z
J Exp Clin Cancer Res; 2021 Apr; 40(1):121. PubMed ID: 33832535
[TBL] [Abstract][Full Text] [Related]
5. MiR-150-5p regulates melanoma proliferation, invasion and metastasis via SIX1-mediated Warburg Effect.
Yang X; Zhao H; Yang J; Ma Y; Liu Z; Li C; Wang T; Yan Z; Du N
Biochem Biophys Res Commun; 2019 Jul; 515(1):85-91. PubMed ID: 31128917
[TBL] [Abstract][Full Text] [Related]
6. The miR-125a/HK2 axis regulates cancer cell energy metabolism reprogramming in hepatocellular carcinoma.
Jin F; Wang Y; Zhu Y; Li S; Liu Y; Chen C; Wang X; Zen K; Li L
Sci Rep; 2017 Jun; 7(1):3089. PubMed ID: 28596599
[TBL] [Abstract][Full Text] [Related]
7. CUE domain-containing protein 2 promotes the Warburg effect and tumorigenesis.
Zhong X; Tian S; Zhang X; Diao X; Dong F; Yang J; Li Z; Sun L; Wang L; He X; Wu G; Hu X; Wang L; Song L; Zhang H; Pan X; Li A; Gao P
EMBO Rep; 2017 May; 18(5):809-825. PubMed ID: 28325773
[TBL] [Abstract][Full Text] [Related]
8. miR-489-3p/SIX1 Axis Regulates Melanoma Proliferation and Glycolytic Potential.
Yang X; Zhu X; Yan Z; Li C; Zhao H; Ma L; Zhang D; Liu J; Liu Z; Du N; Ye Q; Xu X
Mol Ther Oncolytics; 2020 Mar; 16():30-40. PubMed ID: 32258386
[TBL] [Abstract][Full Text] [Related]
9.
Zheng J; Luo J; Zeng H; Guo L; Shao G
Biomed Pharmacother; 2019 Nov; 119():109402. PubMed ID: 31514072
[TBL] [Abstract][Full Text] [Related]
10. ACE2 negatively regulates the Warburg effect and suppresses hepatocellular carcinoma progression via reducing ROS-HIF1α activity.
Dong F; Li H; Liu L; Yao LL; Wang J; Xiang D; Ma J; Zhang G; Zhang S; Li J; Jiang SH; Hu X; Chen J; Bao Z
Int J Biol Sci; 2023; 19(8):2613-2629. PubMed ID: 37215979
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive analysis of microRNA-regulated protein interaction network reveals the tumor suppressive role of microRNA-149 in human hepatocellular carcinoma via targeting AKT-mTOR pathway.
Zhang Y; Guo X; Xiong L; Yu L; Li Z; Guo Q; Li Z; Li B; Lin N
Mol Cancer; 2014 Nov; 13():253. PubMed ID: 25424347
[TBL] [Abstract][Full Text] [Related]
12. Mutual Regulation of MiR-199a-5p and HIF-1α Modulates the Warburg Effect in Hepatocellular Carcinoma.
Li B; He L; Zuo D; He W; Wang Y; Zhang Y; Liu W; Yuan Y
J Cancer; 2017; 8(6):940-949. PubMed ID: 28529605
[TBL] [Abstract][Full Text] [Related]
13. miR-345 inhibits tumor metastasis and EMT by targeting IRF1-mediated mTOR/STAT3/AKT pathway in hepatocellular carcinoma.
Yu M; Xue H; Wang Y; Shen Q; Jiang Q; Zhang X; Li K; Jia M; Jia J; Xu J; Tian Y
Int J Oncol; 2017 Mar; 50(3):975-983. PubMed ID: 28098858
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-7 inhibits tumor growth and metastasis by targeting the phosphoinositide 3-kinase/Akt pathway in hepatocellular carcinoma.
Fang Y; Xue JL; Shen Q; Chen J; Tian L
Hepatology; 2012 Jun; 55(6):1852-62. PubMed ID: 22234835
[TBL] [Abstract][Full Text] [Related]
15. miR-592/WSB1/HIF-1α axis inhibits glycolytic metabolism to decrease hepatocellular carcinoma growth.
Jia YY; Zhao JY; Li BL; Gao K; Song Y; Liu MY; Yang XJ; Xue Y; Wen AD; Shi L
Oncotarget; 2016 Jun; 7(23):35257-69. PubMed ID: 27153552
[TBL] [Abstract][Full Text] [Related]
16. Circular RNA MAT2B Promotes Glycolysis and Malignancy of Hepatocellular Carcinoma Through the miR-338-3p/PKM2 Axis Under Hypoxic Stress.
Li Q; Pan X; Zhu D; Deng Z; Jiang R; Wang X
Hepatology; 2019 Oct; 70(4):1298-1316. PubMed ID: 31004447
[TBL] [Abstract][Full Text] [Related]
17. LINC01554-Mediated Glucose Metabolism Reprogramming Suppresses Tumorigenicity in Hepatocellular Carcinoma via Downregulating PKM2 Expression and Inhibiting Akt/mTOR Signaling Pathway.
Zheng YL; Li L; Jia YX; Zhang BZ; Li JC; Zhu YH; Li MQ; He JZ; Zeng TT; Ban XJ; Yuan YF; Li Y; Guan XY
Theranostics; 2019; 9(3):796-810. PubMed ID: 30809309
[No Abstract] [Full Text] [Related]
18. Activator of thyroid and retinoid receptor increases sorafenib resistance in hepatocellular carcinoma by facilitating the Warburg effect.
Ma L; Liu W; Xu A; Ji Q; Ma Y; Tai Y; Wang Y; Shen C; Liu Y; Wang T; Han J; Zhao C
Cancer Sci; 2020 Jun; 111(6):2028-2040. PubMed ID: 32279388
[TBL] [Abstract][Full Text] [Related]
19. miR-517a promotes Warburg effect in HCC by directly targeting FBP1.
Zhang D; Li Z; Li T; Luo D; Feng X; Liu Y; Huang J
Onco Targets Ther; 2018; 11():8025-8032. PubMed ID: 30519044
[TBL] [Abstract][Full Text] [Related]
20. Physcion increases the sensitivity of hepatocellular carcinoma to sorafenib through miRNA-370/PIM1 axis-regulated glycolysis.
Pan XP; Jiya BR; Wang F; Lan Z
World J Gastrointest Oncol; 2023 Aug; 15(8):1400-1411. PubMed ID: 37663938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
